CRT 2017: ACS & AMI Management - STEMI 2017 Hot Topic: Multivessel Disease Treatment

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

ACS & AMI Management - STEMI 2017 Hot Topic: Multivessel Disease Treatment

Featuring

  • Michael Lipinski
  • Barry Rutherford
  • Timothy Henry
  • Gregg Stone
  • George Dangas
  • Pieter Smits
  • Paul Gurbel
  • Dominick Angiolillo
  • Eric Bates

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Case Introduction: A STEMI Patient with Multivessel Disease - Michael Lipinski
Culprit Only Versus Multivessel Intervention in STEMI: A Word of Caution - Barry Rutherford
Culprit Only Versus Multivessel Intervention in STEMI: Treat Them All! - Timothy Henry
Should Cangrelor Be Used in Most STEMI Patients? - Gregg Stone
Optimal Anticoagulation for Patients With STEMI Bivalirudin Versus Heparin: What Should Be the Standard of Care in 2017? - George Dangas
Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease? - Pieter Smits
With Ticagrelor and Crushing, Cangrelor Has Only a Niche Role - Paul Gurbel
What Should Be the Optimal Duration of DAPT in Patients With STEMI? - Dominick Angiolillo
When and How Should We Use Lytics in STEMI? - Eric Bates

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians
  • Physicians with an interest in Cardiovascular Innovations

Learning Objectives

Related Moments

CRT 2016 Technology & Innovation - Hypertension Definition, Pathophysiology, New Targets and Medical Therapy
Conference
Hypertension Definition, Pathophysiology, New Targets and Medical Therapy at CRT 2016
Advanced Physiology Course (PARIS) - Module 1
Course
1 day course, June 22nd 2018 Paris
Supported By
Contemporary Antiplatelet Strategies In The Treatment Of STEMI Using Primary Percutaneous Coronary Intervention
Journal
Article on Contemporary Antiplatelet Strategies In The Treatment Of STEMI Using Primary Percutaneous Coronary Intervention
Loading Simple Education